Hedge Fund - Euclidean Capital
Rapt Therapeutics Inc. (RAPT)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $16,348,790 | 1.83% | 657,899 | $15.47 |
2 | 2023 - Q3 (2023-09-30) | $10,934,281 | 2.38% | 657,899 | $20.40 |
3 | 2023 - Q2 (2023-06-30) | $10,682,057 | 2.74% | 571,233 | $19.47 |
4 | 2023 - Q1 (2023-03-31) | $7,943,715 | 6.96% | 432,900 | $25.28 |
5 | 2022 - Q4 (2022-12-31) | $8,571,420 | 8.01% | 432,900 | $20.01 |
6 | 2022 - Q3 (2022-09-30) | $10,416,000 | 9.66% | 432,900 | $23.64 |
7 | 2022 - Q2 (2022-06-30) | $7,900,000 | 6.71% | 432,900 | $16.66 |
8 | 2022 - Q1 (2022-03-31) | $9,519,000 | 5.53% | 432,900 | $23.61 |
9 | 2021 - Q4 (2021-12-31) | $15,900,000 | 9.03% | 432,900 | $33.41 |
10 | 2021 - Q3 (2021-09-30) | $19,722,000 | 9.58% | 635,177 | $33.05 |
11 | 2021 - Q2 (2021-06-30) | $23,391,000 | 7.59% | 735,801 | $23.36 |
12 | 2021 - Q1 (2021-03-31) | $16,335,000 | 5.46% | 735,801 | $20.61 |
13 | 2020 - Q4 (2020-12-31) | $14,532,000 | 3.07% | 735,801 | $27.18 |
The displayed share prices are average quarterly stock market prices.